Today's post is the third in an ongoing series we're publishing on key players in healthcare vertical integration . Nearly everyone in...

Last year at this time, we enjoyed reading Dan Diamond's piece for the Washington Post on how reversing the recent decline in U.S....

In last week's blog post, we delved into the what and why behind the current surge in interest and demand for GLP-1s. And it's clear that...

A full 6% of US adults are taking GLP-1s. In this post, we break down what we do—and don't—know about these medications as of August 2024.

Healthcare disruption has been a hot (and noisy) topic in recent years. For the last decade, the healthcare industry has been rich in...

Everybody likes to pick on the PBMs (pharmacy benefit managers) these days. It's a sector of healthcare whose business model...

Something we're starting new this week: Union Healthcare Insight's Slide of the Week. Over the past 12 months we've been in business, our...

This month, my family and I were affected by two different drug shortages. First, we couldn’t fill a standing prescription for an ADHD...

Cost savings for seniors are real—but there are thousands of ways to squeeze the balloon When the Inflation Reduction Act passed in 2022,...